MarketScreener’s Quantum Computing Thematic List

MarketScreener has released a thematic list highlighting quantum computing as a future investment opportunity, pointing to the technology’s potential to transform industries and deliver exponential growth. Quantum computers differ from classical machines by using qubits, which can represent both 0 and 1 simultaneously, dramatically boosting processing power. A calculation that would take a conventional computer 10,000 years could be completed by a quantum machine in minutes.

The report underscores how this leap in capability could disrupt cryptography, pharmaceutical research, artificial intelligence, finance and logistics. The global quantum computing market was valued at roughly $500 million in 2021 and is forecast to reach $65 billion by 2030, a compound annual growth rate (CAGR) above 50%. Adoption by companies and governments, along with heavy R&D investment, is expected to fuel this expansion.

For investors, the thematic list gathers publicly traded companies—from startups to established multinationals—active in the quantum computing space, framing the sector as a long-term portfolio consideration.

Behind the Quantum Hype: Real Promise, Uncertain Timeline

The Sectors That Could Be Upended

The areas identified in the thematic list—cryptography, drug discovery, financial modeling, and logistics optimization—are all computationally intensive. Quantum computing’s ability to solve complex problems exponentially faster could give early adopters a significant edge. In finance, for instance, quantum algorithms could revolutionize risk analysis and portfolio optimization; in pharma, they could slash the time needed to simulate molecular interactions.

Advertisement

The Growth Projection—and the Catch

The $65 billion market estimate for 2030 depends on continued breakthroughs in hardware stability, error correction, and commercial applications that do not yet exist at scale. While the CAGR of over 50% is impressive, it starts from a low base, and the actual timeline for widespread commercial viability remains uncertain. The list itself is a high-level grouping; it does not provide individual company analysis or risk grading, so the investment case relies heavily on the overall theme rather than on specific corporate fundamentals.